Cohere Health Taps Veteran Physician Exec for AI Leadership

BOSTON, MA – February 24, 2026 – Cohere Health, a company at the forefront of applying artificial intelligence to healthcare administration, has appointed Dr. Mark Leenay to its board of directors. The move signals a deliberate strategy to infuse its technology-driven platform with seasoned clinical and health plan leadership, aiming to accelerate its mission of streamlining payer-provider collaboration.

Dr. Leenay, a board-certified physician in family medicine and geriatrics, brings over two decades of executive experience from some of the nation's largest healthcare organizations, including WellCare, Optum, and UnitedHealthcare. His appointment is seen as a significant step for Cohere Health as it scales its AI-powered solutions designed to untangle the complexities of medical cost management and prior authorization.

"Dr. Leenay's appointment comes at a pivotal time as Cohere Health continues building momentum with our domain-specific, agentic AI and enterprise clinical intelligence platform," said Siva Namasivayam, CEO of Cohere Health, in a statement. "He brings a rare perspective that combines physician-level clinical insights with executive health plan leadership–strategically aligned to our mission to help health plans transform decision-making throughout the care continuum."

The Doctor in the Machine

The appointment highlights a critical trend in the health tech sector: the necessity of embedding deep clinical knowledge into the architecture of AI. As algorithms become more powerful, the industry recognizes that technology alone cannot solve healthcare's deeply human and complex challenges. Dr. Leenay’s background represents the fusion of expertise Cohere Health is banking on.

His career is a map of the modern healthcare landscape. At WellCare, he served as Executive Vice President and Chief Medical Officer, overseeing clinical strategy for millions of Medicare and Medicaid members. Before that, he spent over a decade in senior leadership at UnitedHealth Group and Optum, focusing on clinical programs and medical management. More recently, as Chief Medical Officer at ChenMed, he was immersed in value-based primary care for seniors, a model that prioritizes patient outcomes over service volume.

This unique blend of experience—as a practicing physician, a manager of large-scale health plan operations, and a leader in value-based care—provides a 360-degree view of the very problems Cohere Health aims to solve. His role is expected to guide the company's AI development, ensuring its solutions are not only technologically sophisticated but also clinically sound, ethically responsible, and practical for both payers and providers.

"Dr. Leenay's experience and insights as both a physician and health plan leader significantly strengthen Cohere Health's governance and strategic direction," noted Dr. Gary Gottlieb, executive chair of Cohere Health. This underscores the belief that to truly fix systemic inefficiencies, the solutions must be co-designed by those who have lived within the system.

A Strategic Play in the Payer-Provider Arena

Cohere Health operates in the notoriously challenging space of utilization management, specifically targeting the friction-laden process of prior authorization. The company’s core offering is a clinical intelligence platform that uses what it calls “agentic AI” to automate and optimize care decisions, aiming to move beyond simple denials and approvals to foster genuine collaboration.

This technology is designed to create a shared, intelligent workflow between health plans (payers) and healthcare providers. By integrating with electronic health records and using AI to suggest evidence-based care pathways, the platform seeks to reduce the administrative burden that plagues clinicians while ensuring patients receive appropriate care without unnecessary delays. This approach has helped the company gain significant traction, evidenced by its inclusion on both the Inc. 5000 list of fastest-growing companies and TIME's World's Top HealthTech Companies 2025 list.

Bringing Dr. Leenay onto the board is a calculated business move to leverage this momentum. His extensive network and deep understanding of health plan priorities—particularly in medical cost management—are invaluable assets. He is positioned to act as both a guide and a bridge, helping Cohere Health refine its product to meet the precise needs of large payers and accelerate partnerships within the industry.

"I believe clinically trained AI can make a meaningful difference in supporting patient care," Dr. Leenay stated. "As a member of the board of directors, I look forward to supporting Cohere Health's mission by connecting health plans and providers to improve efficiency and address the challenges of rising healthcare costs."

Beyond Buzzwords to the Bottom Line

For health plans and providers weary of tech promises, the ultimate measure of success is tangible results. Cohere Health has built its reputation on delivering measurable value, frequently citing an 8x return on investment (ROI) for health plans and a 94% provider satisfaction rate.

While these figures are company-reported, they form the core of its value proposition. The 8x ROI is attributed to a combination of reduced administrative overhead, a decrease in unnecessary medical spending through optimized care pathways, and improved operational efficiency. The high provider satisfaction rate stems from a platform designed to be provider-friendly, offering faster approvals and clearer clinical guidance, thereby reducing the burnout associated with traditional, manual prior authorization processes.

Dr. Leenay's expertise is directly relevant to substantiating and expanding on these outcomes. His career has been dedicated to navigating the balance between cost containment and quality of care. His involvement will likely focus on ensuring Cohere's AI continues to drive these metrics, proving that technology can simultaneously bend the cost curve and improve the experience for clinicians on the front lines.

This focus on quantifiable impact is crucial as AI moves from a theoretical advantage to a practical necessity in healthcare. The industry is awash with AI solutions, but those that can demonstrate clear, auditable financial and clinical benefits are the ones poised to lead the market. Cohere Health's strategic appointment of Dr. Leenay reinforces its commitment to being a leader in that evidence-based transformation. The appointment reinforces the idea that the most effective AI will be the one that successfully marries advanced algorithms with the wisdom and experience of seasoned healthcare professionals to solve long-standing industry problems.